The reason for the discrepancies in the findings of whether p53 codon 72 polymorphism confers vulnerability to bladder cancer may include the ethnic heterogeneity, the sample types (blood vs. tumor tissue), the presence of HPV-DNA, the sample selection bias, and the cancer pathological differences. Here, TP53 is linked to urinary bladder cancer.